Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy

Virginie Neirinckx, Hakan Hedman, Simone P. Niclou*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science